✦ LIBER ✦

TCT-37: Long-Term Safety and Clinical Efficacy Outcomes of the Paclitaxel-Eluting Stent from a Patient-Level Pooled Analysis of the TAXUS Clinical Trials

Book ID: 113446198
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 220 KB
Volume: 104
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2009.08.045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-365: Final 5-Year Outcomes from the

TCT-365: Final 5-Year Outcomes from the TAXUS V de novo Trial: Long-Term Safety and Effectiveness of the Paclitaxel-Eluting TAXUS Stent in Complex Lesions

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 201 KB

Randomized comparison of everolimus-elut

Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: pooled analysis of 3-year clinical outcomes from the Spirit II and III Trials

✍ Alexandra J. Lansky; James B. Hermiller; Robert Applegate; Adriano Caixeta; Paul 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Real world safety and efficacy of the Ja

Real world safety and efficacy of the Janus tacrolimus-eluting stent: Long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry

✍ Corrado Tamburino; Maria Elena Di Salvo; Davide Capodanno; Piera Capranzano; Ros 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Abstract ## Objectives: We sought to evaluate the safety and performance of the Janus Tacrolimus‐Eluting stent (TES) in an unselected population of patients, without application of restrictive clinical or angiographic criteria. ## Background: Continued attention to the safety, efficacy, and d

TCT-30: A Large-Scale Randomized Compari

TCT-30: A Large-Scale Randomized Comparison of Everolimus-Eluting and Paclitaxel- Eluting Stents: Three-Year Clinical Outcomes from the SPIRIT IV Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 128 KB

TCT-35: A Large-Scale Randomized Compari

TCT-35: A Large-Scale Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents: Two-Year Clinical Outcomes from the SPIRIT IV Trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 182 KB

TCT-649 Safety and Efficacy of Overlappi

TCT-649 Safety and Efficacy of Overlapping Second Generation Drug-Eluting Stents Based Upon 2-year Clinical outcomes. Results from the Pooled Analysis of Five Trials from the International Global RESOLUTE Program

✍ Vasim Farooq; Roberto Diletti; Hector Garcia-Garcia; Laura Mauri; Jorge Belardi; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB